Dawn J. Caster

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Brad H. Rovin, Y K Onno Teng, Ellen M. Ginzler et al. · The Lancet · 2021 · 593 citations

Medicine, Immunology, Nephrology +10

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Jürgen Floege, Sean Barbour, Daniel Cattran et al. · Kidney International · 2019 · 258 citations · Full text

Medicine, Internal Medicine, Nephrology +17

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 215 citations · Full text

Medicine, Internal Medicine, Nephrology +12

Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Brad H. Rovin, Dawn J. Caster, Daniel C. Cattran et al. · Kidney International · 2019 · 185 citations · Full text

Medicine, Nephrology, Pathology +17

Safety and Efficacy of <scp>Long‐Term</scp> Voclosporin Treatment for Lupus Nephritis in the Phase 3 <scp>AURORA</scp> 2 Clinical Trial

Amit Saxena, Ellen M. Ginzler, Keisha L. Gibson et al. · Arthritis & Rheumatology · 2023 · 116 citations · Full text

Medicine, Nephrology, Pharmacotherapy +10